{"id":"NCT01967550","sponsor":"Novartis","briefTitle":"Efficacy and Safety of Diclofenac DDEA 2.32 % in Patient Suffering From Knee Osteoarthritis (OA)","officialTitle":"A 4-week, Randomized, Double-blind, Multi-center, Vehicle-controlled, Parallel Group Study to Assess the Efficacy and Safety of Diclofenac Diethylamine 2.32% Gel for the Relief of Signs and Symptoms in Patients With Knee Osteoarthritis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-10","primaryCompletion":"2014-05","completion":"2014-05","firstPosted":"2013-10-23","resultsPosted":"2015-06-03","lastUpdate":"2015-06-03"},"enrollment":304,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Osteoarthritis, Knee"],"interventions":[{"type":"DRUG","name":"diclofenac diethylamine, DDEA 2.32% gel","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"diclofenac diethylamine, DDEA 2.32% gel","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This study will evaluate the efficacy and safety of diclofenac DDEA 2.32 % in patient suffering from knee osteoarthritis (OA).","primaryOutcome":{"measure":"Measure: Pain On Movement (POM)","timeFrame":"2 weeks","effectByArm":[{"arm":"Diclofenac Diethylamine, DDEA 2.32% Gel","deltaMin":42.9,"sd":23.8},{"arm":"Placebo","deltaMin":42.1,"sd":23.5}],"pValues":[]},"eligibility":{"minAge":"50 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":null},"locations":{"siteCount":5,"countries":["Germany"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":153},"commonTop":["Headache","Nasopharyngitis","Contusion","Back pain","Abdominal pain upper"]}}